Calendar Teva Pharmaceutical Industries Limited

Equities

TEVA

US8816242098

Market Closed - Nyse 01:30:02 27/04/2024 am IST 5-day change 1st Jan Change
13.81 USD +4.23% Intraday chart for Teva Pharmaceutical Industries Limited +7.39% +32.28%

Chart calendar Teva Pharmaceutical Industries Limited

fab2de2e4aa117a9385.MqWxlHFEQzi5LEnSw7cfCMmyxE7J5LhSJyvtruSZGjQ.Y9_3-DwyNUrbbiuqlfVAbLvXgg2kvvA6dn2vnIjaRWZi_d7ZBAIZcOMaeQ~30219865a7d5697e4869cfc16b2cf029

Upcoming events on Teva Pharmaceutical Industries Limited

08/05/2024 04:30 pm Q1 2024 Earnings Release
08/05/2024 05:30 pm Q1 2024 Earnings Call
06/06/2024 06:30 pm Annual General Meeting
07/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
05/02/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Teva Pharmaceutical Industries Limited

03/04/2024 Schizophrenia International Research Society Congress
31/01/2024 06:30 pm Q4 2023 Earnings Call
31/01/2024 05:30 pm Q4 2023 Earnings Release
08/01/2024 09:45 pm JPMorgan Healthcare Conference
28/11/2023 06:50 pm Evercore ISI HealthCONx Conference
08/11/2023 06:30 pm Q3 2023 Earnings Call
08/11/2023 05:30 pm Q3 2023 Earnings Release
02/11/2023 Huntington Study Group Meeting
04/10/2023 05:30 pm Sanofi Pharmaceutical Industry Company and Teva Pharmaceutical Industries Ltd Collaboration Agreemen
11/09/2023 06:10 pm Morgan Stanley Global Healthcare Conference
10/09/2023 12:30 am Psych Congress
08/09/2023 Psych Congress - Poster #104
08/09/2023 Psych Congress - Poster #130
08/09/2023 Psych Congress - Poster #90
08/09/2023 Psych Congress - Poster #134
08/09/2023 Psych Congress - Poster #109
08/09/2023 Psych Congress - Poster #139
08/09/2023 Psych Congress - Poster #110
08/09/2023 Psych Congress - Poster #89
08/09/2023 Psych Congress - Poster #105

Past dividends on Teva Pharmaceutical Industries Limited

27/11/2017 Quarterly 0.07225 USD
25/08/2017 Quarterly 0.07225 USD
01/06/2017 Quarterly 0.289 USD
28/02/2017 Quarterly 0.289 USD
01/12/2016 Quarterly 0.289 USD
18/08/2016 Quarterly 0.289 USD
20/05/2016 Quarterly 0.289 USD
25/02/2016 Quarterly 0.289 USD
13/11/2015 0.289 USD
18/08/2015 0.289 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
16 887
17 254
-2.13%
16 659
16 599
0.36%
15 878
16 125
-1.53%
14 925
14 952
-0.18%
15 846
15 349
3.24%

15 863

EBITDA
Million USD
Released
Forecast
Spread
4 685
4 678
0.16%
4 912
4 899
0.26%
4 911
4 862
1.01%
4 598
4 702
-2.22%
4 818
4 520
6.58%

4 672

EBIT
Million USD
Released
Forecast
Spread
4 142
4 108
0.82%
4 388
4 333
1.27%
4 401
4 355
1.05%
4 139
4 163
-0.57%
4 361
4 050
7.67%

4 249

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-1 265
1 262
-200.22%
-4 406
1 060
-515.66%
658
1 625
-59.51%
0,00
0,00
-
-624
-916
31.88%

2 631

Net income
Million USD
Released
Forecast
Spread
-999
-806
-23.87%
-3 990
-3 864
-3.27%
417
954
-56.3%
-2 353
-494
-375.86%
-559
343
-262.9%

1 538

EPS
USD
Released
Forecast
Spread
-0,91
-0,73
-23.86%
-3,64
-3,48
-4.56%
0,38
0,76
-50.04%
-2,12
-0,45
-370.01%
-0,50
-0,24
-107.75%

1,25

Announcement Date12/02/2010/02/2109/02/2208/02/2331/01/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
4 100
4 283
-4.28%
3 661
3 754
-2.48%
3 786
3 775
0.29%
3 595
3 854
-6.72%
3 884
3 905
-0.54%
3 661
3 589
2%
3 878
3 720
4.24%
3 850
3 736
3.05%
4 457
4 010
11.15%

3 741


3 991


4 005


4 150


3 743

EBITDA
Million USD
Released
Forecast
Spread
1 373
1 343
2.21%
1 135
1 096
3.54%
1 134
1 138
-0.39%
1 089
1 181
-7.77%
1 240
1 332
-6.93%
899
1 119
-19.69%
1 125
1 079
4.22%
1 134
1 186
-4.41%
1 660
1 394
19.06%

1 042


1 153


1 197


1 319




EBIT
Million USD
Released
Forecast
Spread
1 248
1 207
3.37%
1 013
976
3.84%
1 019
1 012
0.67%
977
1 048
-6.8%
1 130
1 165
-3.02%
785
984
-20.19%
1 011
956
5.8%
1 020
1 063
-4.04%
1 546
1 251
23.56%

917


1 033


1 079


1 164


1 027

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-175
370
-147.3%
-971
403
-340.94%
-1 160
393
-395.17%



-1 100
430
-355.81%






75,0
443
-83.07%
507
180
181.67%

141


187


171


177




Net income
Million USD
Released
Forecast
Spread
-159
264
-160.24%
-955
335
-384.9%
-232
236
-198.45%
56,0
96,7
-42.1%
-1 221
584
-309.12%
-205
58,2
-452.48%
-863
-12,2
-6951.9%
80,0
-192
141.73%
461
1 055
-56.3%

32,0


69,0


72,5


64,2




EPS
USD
Released
Forecast
Spread
-0,14
0,08
-273.44%
-0,86
0,28
-404.92%
-0,21
0,06
-475.6%
0,05
0,09
-42.12%
-1,10
0,50
-319.89%
-0,18
0,05
-447.89%
-0,77
-0,01
-7023.03%
0,07
-0,35
119.73%
0,41
0,53
-21.99%

-0,05


-0,40


0,00


0,67




Announcement Date09/02/2203/05/2226/07/2203/11/2208/02/2310/05/2302/08/2308/11/2331/01/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. TEVA Stock
  4. Calendar Teva Pharmaceutical Industries Limited